Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Blair Olson"'
Autor:
Jaimie P. Meyer, Wilson Vincent, Trace Kershaw, Timothy G. Heckman, Blair Olson, Nathan B. Hansen, Kathleen J. Sikkema
Publikováno v:
Qual Life Res
In the United States, approximately 45% of persons living with HIV (PLHIV) are ≥ 50 years of age. Many older PLHIV have multi-morbidities that complicate HIV infection and/or interfere with, or are exacerbated by, antiretroviral treatment. Physical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cf5682c60b81069e5ca46fc6ed2300
https://doi.org/10.1007/s11136-019-02271-0
https://doi.org/10.1007/s11136-019-02271-0
Autor:
John N. Caviness, Douglas R. Langbehn, Kevin Duff, Jane S. Paulsen, Jess G. Fiedorowicz, Kevin M. Biglan, William Adams, Leigh J. Beglinger, Blair Olson
Publikováno v:
Journal of Huntington's Disease. 4:251-260
Background In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by "practice effects" (PE)--performance improvement from prior exposure to test materials. Objective A practice run-in ("dual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590be82d245629daca7850801de1adfc
https://doi.org/10.3233/jhd-150159
https://doi.org/10.3233/jhd-150159
Autor:
Jess G. Fiedorowicz, Blair Olson, Jane S. Paulsen, Kevin M. Biglan, Leigh J. Beglinger, Douglas R. Langbehn, John N. Caviness, William Adams
Publikováno v:
Journal of Huntington's Disease. 3:139-144
BACKGROUND "Practice effects" (PE), or performance improvements due to prior exposure to testing, are known to confound cognitive test results, particularly when short intervals occur between two test sessions. OBJECTIVE We examined two subsamples wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce2d633f578bcd70e1016ebc8b65394
https://doi.org/10.3233/jhd-140100
https://doi.org/10.3233/jhd-140100
Autor:
Kevin M. Biglan, Ricardo E. Jorge, Jane S. Paulsen, Leigh J. Beglinger, Blair Olson, John N. Caviness, William Adams, Robert G. Robinson, Karl Kieburtz, Jess G. Fiedorowicz, Douglas R. Langbehn
Publikováno v:
Movement Disorders. 29:401-405
Background The objective of this study was to evaluate citalopram for executive functioning in Huntington's disease (HD). Methods The study was randomized, double-blind, and placebo-controlled. Thirty-three adults with HD, cognitive complaints, and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c330d18671f3929a6c0d4418ffc8456a
https://doi.org/10.1002/mds.25750
https://doi.org/10.1002/mds.25750
Autor:
Leigh J, Beglinger, William H, Adams, Douglas, Langbehn, Jess G, Fiedorowicz, Ricardo, Jorge, Kevin, Biglan, John, Caviness, Blair, Olson, Robert G, Robinson, Karl, Kieburtz, Jane S, Paulsen
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 29(3)
The objective of this study was to evaluate citalopram for executive functioning in Huntington's disease (HD).The study was randomized, double-blind, and placebo-controlled. Thirty-three adults with HD, cognitive complaints, and no depression (Hamilt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::623867ea7fd101661127c4c968ad2e85
https://pubmed.ncbi.nlm.nih.gov/24375941
https://pubmed.ncbi.nlm.nih.gov/24375941